KRAS and cancer: Kamerkar et al. demonstrated that exosomes derived from mesenchymal cells artificially incorporated siRNA or short hairpin (sh) RNA specific for oncogenic KRAS suppressed cancer in a plurality of mouse models of pancreatic cancer [51].